Fundz

Clene reported raising $7.31 Million in an initial SEC Form D filing, from an offering of $7.31 Million

PUBLIC · CLNNOct 09, 2024

Amount Raised

$7.31 Million

$7.31 Million sold, per SEC Form D (first sale Oct 1, 2024)

Round Type

Venture

Salt Lake CityBiotechnologyTherapeuticsPharmaceuticalBiopharma

Quick answer

Clene Nanomedicine raised $7.31 Million in a funding round, dated October 1, 2024. Clene Nanomedicine is based in Salt Lake City, Utah, United States.

How much did Clene Nanomedicine raise?
Clene Nanomedicine raised $7.31 Million in a funding round on October 1, 2024.
What does Clene Nanomedicine do?
Clene Inc., (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and..
Where is Clene Nanomedicine based and how big is it?
Clene Nanomedicine is based in Salt Lake City, Utah, United States. Fundz records about 78 employees.
Who are the decision-makers at Clene Nanomedicine?
Fundz holds 1 contact at Clene Nanomedicine, including the Vice President, Translational Medicine. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Pharmaceutical around the same time

Companies in the same sectors as Clene Nanomedicine that raised within 45 days of this round, from Fundz verified event records.

  • Bio Green Med Solution, Inc. raised $2.1M (Seed) on November 14, 2024.
  • Ensho Therapeutics raised $5M on October 24, 2024.
  • Seaport Therapeutics raised $225M (Series B) on October 21, 2024.
  • Seaport Therapeutics raised $226M on October 18, 2024.
  • SystImmune raised $7.9M on October 18, 2024.
  • OnKure Therapeutics raised $65M on October 4, 2024.

Who to call at Clene Nanomedicine, and when

A new round usually means Clene Nanomedicine is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Clene Nanomedicine raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Clene Nanomedicine, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Clene Nanomedicine. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Clene Nanomedicine

Location

6550 SOUTH MILLROCK DRIVE, SUITE G50

Salt Lake City, Utah, United States

About

Clene Inc., (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson’s disease and multiple sclerosis. CNM-Au8® is an investigational first-in-class therapy that improves central nervous system cells’ survival and function via a mechanism that targets mitochondrial function and the NAD pathway while reducing oxidative stress. CNM-Au8® is a federally registered trademark of Clene Nanomedicine, Inc.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Clene Nanomedicine raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsKaren, Vice President, Translational MedicineSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Clene Nanomedicine's next move

See what Strategic adds

Clene Nanomedicine raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.